
1. j clin virol. 2018 dec;109:22-28. doi: 10.1016/j.jcv.2018.10.005. epub 2018 oct
13.

evaluation performance characteristics hepatitis b e antigen serologic
assays.

mixson-hayden t(1), purdy ma(1), ganova-raeva l(1), mcgovern d(1), forbi jc(1),
kamili s(2).

author information: 
(1)division viral hepatitis, centers disease control prevention,
atlanta, ga 30329 united states.
(2)division viral hepatitis, centers disease control prevention,
atlanta, ga 30329 united states. electronic address: skamili@cdc.gov.

background: hepatitis b e antigen (hbeag) considered indicator high
hepatitis b virus (hbv) replication. performance characteristics commercially 
available hbeag assays determined, thus unknown whether lack 
of hbeag detection test sensitivity hbv basal core promoter 
precore mutations.
objectives: studied correlation hbeag reactivity hbv dna
levels three commercially available hbeag assays using 335 hbsag hbv dna
positive serum/plasma samples.
study design: diagnostic sensitivity determined serial dilutions 
hbeag standard. limit hbeag detection estimated regression 1
iu/ml (centaur), 97 iu/ml (diasorin) 129 iu/ml (vitros). 335
samples, enough sample volume remained 253 samples head-to-head comparison
of assays.
results: 81 (32%), 41 (16%) 36 (14%) samples hbeag positive by
the centaur, diasorin vitros assays, respectively. compared the
fda-approved centaur assay specificity two assays 98%, while
sensitivity 47% diasorin assay 41% vitros assay.
significant association found hbeag positive samples hbv dna
levels >20,000 iu/ml; 31% hbeag negative samples (centaur) hbv dna levels 
>20,000 iu/ml, 26% hbeag positive samples hbv dna levels <20,000 iu/ml and
5 hbeag positive samples hbv dna levels <2000 iu/ml.
conclusion: discordance seen hbeag assays, indicating reliance 
on hbeag alone marker high hbv replication misleading. detection
and quantification hbv dna remains accurate reliable marker hbv
replication.

published elsevier b.v.

doi: 10.1016/j.jcv.2018.10.005 
pmid: 30388663  [indexed medline]

